TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials. February 25, 2000
TCL Archive New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment. April 25, 2008
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
